From: Annual public health and economic benefits of seasonal influenza vaccination: a European estimate
Data used for modeling | Vaccination target group | Germany | France | Italy | Spain | UK | Poland | Slovakia | Sweden | EU-27 |
---|---|---|---|---|---|---|---|---|---|---|
Influenza attack rate | 6-23 months | 19.10% | 19.10% | 19.10% | 19.10% | 19.10% | 19.10% | 19.10% | 19.10% | 19.10% |
Healthy, 2–64 years (health care workers and pregnant women) | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | |
Underlying chronic conditions, 2–64 yrs | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | 3.64% | |
Elderly | 4.91% | 4.91% | 4.91% | 4.91% | 4.91% | 4.91% | 4.91% | 4.91% | 4.91% | |
Influenza-related GP visits rate | 6-23 months | 5.99% | 5.20% | 5.97% | 3.45% | 7.21% | 2.97% | 5.40% | 2.05% | |
Healthy, 2–64 years (health care workers and pregnant women) | 2.35% | 2.04% | 2.25% | 1.35% | 1.18% | 1.17% | 2.34% | 2.55% | ||
Underlying chronic conditions, 2–64 yrs | 2.35% | 2.04% | 2.25% | 1.35% | 1.18% | 1.17% | 2.34% | 2.55% | ||
Elderly | 1.58% | 1.37% | 0.89% | 0.94% | 0.60% | 0.78% | 0.58% | 1.01% | ||
Influenza-related hospitalizations/100,000 | 6-23 months | 127.90 | 73.70 | 76.90 | 67.60 | 131.10 | 134.70 | 205.50 | 106.10 | |
Healthy, 2–64 years (health care workers and pregnant women) | 12.70 | 7.30 | 7.60 | 6.70 | 4.90 | 13.30 | 20.30 | 10.50 | ||
Underlying chronic conditions, 2–64 yrs | 34.30 | 19.80 | 20.60 | 18.10 | 17.90 | 36.10 | 55.10 | 28.50 | ||
Elderly | 179.50 | 103.40 | 107.90 | 94.90 | 130.00 | 189.00 | 288.40 | 148.90 | ||
Influenza-related mortality/100,000 | 6-23 months | 1.62 | 0.80 | 0.83 | 1.09 | 1.28 | 2.02 | 3.07 | 1.93 | |
Healthy, 2–64 years (health care workers and pregnant women | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
Underlying chronic conditions, 2–64 yrs | 4.90 | 4.86 | 5.06 | 2.31 | 3.87 | 6.10 | 9.28 | 5.84 | ||
Elderly | 84.70 | 84.00 | 87.50 | 57.05 | 66.90 | 105.00 | 160.55 | 101.00 |